People · Operator
Named in public records as an officer, director or promoter · active 2015–2021 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| OncoQuest Inc. | — | Pharmaceuticals | Series A | $13.0M | $402.6M | 2015 |
| Quest PharmaTech Inc. | — | Pharmaceuticals | Seed | $1.5M | $57.1M | 2015 |
| Oncoquest Pharma Usa, Inc | — | Pharmaceuticals | Pre-Seed | $870K | $10.5M | 2020 |
Ragupathy Madiyalakan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ragupathy Madiyalakan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Pierre Vermette | 2 | 2 |
| Bin Huang | 2 | 2 |
| Thomas Woo | 2 | 2 |
| Paul Van Damme | 2 | 2 |
| Madi Madiyalakan | 1 | 1 |
| Lyn Lim | 1 | 1 |
| Karthik Radhakrishnan | 1 | 1 |
| Ian McConnan | 1 | 1 |
| Alex Jung | 1 | 1 |
| Lorne Meikle | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.